Kamada Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.39B 465M 398M 373M 341M 640M 44.5B 649M 4.4B 1.72B 22.35B 1.75B 1.71B 73.94B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.39B 465M 398M 373M 341M 640M 44.5B 649M 4.4B 1.72B 22.35B 1.75B 1.71B 73.94B | EV / Sales 2026 * |
2.29x | EV / Sales 2027 * | 2.07x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
| Chairman | 55 | 12/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 465M | |
| +0.90% | +3.80% | +39.43% | -1.22% | 83.28B | |
| -1.69% | +23.30% | -25.53% | -36.93% | 57.77B | |
| +8.86% | +129.20% | +453.51% | +30.65% | 57.92B | |
| -1.46% | +0.19% | -0.81% | +29.66% | 51.75B | |
| +1.74% | +4.43% | +11.41% | +172.02% | 49.35B | |
| +1.13% | +3.31% | +55.82% | -18.22% | 32.03B | |
| +0.46% | +6.37% | +47.71% | +96.99% | 25.91B | |
| +1.19% | +9.17% | +3.12% | +228.73% | 22.74B | |
| -5.74% | +1.91% | +2.59% | +825.47% | 16.08B | |
| Average | -0.01% | +20.19% | +65.25% | +147.46% | 44.09B | |
| Weighted average by Cap. | -0.03% | +24.91% | +79.97% | +75.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 606M 203M 174M 162M 149M 279M 19.39B 283M 1.92B 749M 9.74B 761M 745M 32.22B | 673M 225M 193M 181M 165M 310M 21.55B 314M 2.13B 832M 10.83B 846M 827M 35.81B |
| Net income | 84.8M 28.37M 24.3M 22.74M 20.81M 39.06M 2.71B 39.58M 269M 105M 1.36B 107M 104M 4.51B | 104M 34.83M 29.84M 27.92M 25.56M 47.96M 3.33B 48.6M 330M 129M 1.67B 131M 128M 5.54B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
